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Comprehensive Review

Critical Issues in the Assessment of
Disability in Schizophrenia
Margaret M. McClure,1, 2 Philip D. Harvey 1, 2

Abstract
Individuals with schizophrenia exhibit functional disability across a wide array of domains. These patients
experience impairments in their social competence, vocational aptitude, everyday living skills, and self-care
abilities, which in the majority of patients are severe enough to prevent the return to independent living,
even after hallmark symptoms such as hallucinations and delusions are remitted. Unfortunately, assessment
of the magnitude of disability in individual patients is hindered by several factors, such as reduced capability in the area of self-evaluation and inaccuracies in self-report, as well as the presence of potential contributing variables such as depression and poor self-esteem. Furthermore, additional barriers to recovery exist,
such as fear of losing disability payments and factors such as discrimination. Performance-based measures
of functioning are new and promising instruments for assessing the competencies of patients and address
many of the problems with other methods of assessing disability. These measures could greatly aid clinicians in understanding the schizophrenia disease and recovery process, expanding treatment goals beyond
the currently targeted positive and negative symptoms.
Key Words: Schizophrenia, Disability, Functional Outcome, Recovery,
Performance-Based Assessments

Introduction
Individuals with schizophrenia frequently achieve remission of hallmark symptoms of psychosis. However, few
achieve true recovery. Instead, individuals with schizophrenia experience chronic disability in many domains of
functioning, such as social competence, vocational achievement, everyday living skills, and self-care. In the current paper, we review domains of disability in schizophrenia, as well as methods for assessing individual disability.
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Functional Disability as the Core
of Schizophrenia

Over the last decade, the World Health Organization
has changed its perspective on evaluating disability from
focusing on the rate of mortality caused by the disease to
other factors reflecting morbidity of illness, such as reduced
quality of life and impaired engagement in activities. This
shift has underscored the chronic burden schizophrenia
creates for patients, caregivers, and society. The direct cost
of treating schizophrenia has risen from $44 billion (1) to
$62.7 billion (2) over the last decade. The indirect cost of
the disability associated with schizophrenia is approximately
another $32 billion (2). The social and emotional costs of
the illness are more difficult to quantify, particularly with
an economic model. In fact, schizophrenia has been characterized as the most disabling of all mental illnesses (3).
Unfortunately, although pharmacological advances have
been effective at treating positive and negative symptoms of
schizophrenia (4), the rate of true recovery from the illness,
defined by a return to independent living, remains relatively
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unchanged from what it was a century ago (5). In addition,
evidence has emerged suggesting that the functional disability of individuals with schizophrenia is in fact, a heritable trait. For example, Kendler et al. (6) found that among
relatives of individuals with schizophrenia, the relative odds
ratio of having occupational dysfunction (OR=3.4), compared to relatives of healthy individuals, was greater than the
odds ratio for having positive schizotypy (OR=1.93), a trait
that is almost universally acknowledged to run in families of
individuals with schizophrenia. Thus, functional disability
within this population is not only severe, but it also appears
to be heritable, suggesting that it is, in fact, a core aspect of
the schizophrenia illness.

Domains of Functional Disability in
Schizophrenia

The functional disability of schizophrenia is also pervasive and is present across a wide range of domains. Individuals with schizophrenia demonstrate impairments in their
social outcomes, vocational achievement, everyday living
skills, and self-care.

Social Outcomes
Individuals with schizophrenia exhibit severe deficits
in their social functioning (7, 8). Individuals with schizophrenia are frequently isolated from others and have been
found to have smaller social networks than control subjects
(9, 10). When individuals with schizophrenia do communicate with others, they frequently have difficulty maintaining
appropriate conversations and expressing their needs and
feelings (11, 12). In addition, individuals with schizophrenia frequently fail to achieve major social milestones, such
as getting married. For example, in one study of over 1,400
individuals with schizophrenia, only 12% were married (13).
In fact, almost two-thirds of individuals with schizophrenia
are unable to fulfill basic social roles such as spouse or parent (11).

Vocational Achievement
Rates of competitive employment for individuals with
schizophrenia are estimated to be approximately 20% (14),
and, even with optimal support, employment rates for individuals with schizophrenia only rise to about 60% (15). In
addition, although individuals with schizophrenia are frequently able to obtain employment while participating in
supportive employment programs, many patients lose these
jobs once the employment services cease (16). Many individuals with schizophrenia, in addition, received less education than would be expected given other demographic variables (10), which unfortunately may impede their abilities
to gain employment during periods of symptoms remission
(13).
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Everyday Living Skills
Individuals with schizophrenia also experience problems completing tasks that require the use of everyday living skills, such as cooking, cleaning, money management,
and using public transportation (17-20). Few individuals
with schizophrenia are able to live independently. In fact,
one large study of individuals with schizophrenia found that
only 8% were living on their own and responsible for payment for their accommodations (21).

Self-Care
Individuals with schizophrenia experience many problems with self-care, most notably related to their poor medication adherence. Non-compliance for antipsychotic treatment in this population is estimated at approximately 50%
(22). In addition, individuals with schizophrenia rarely seek
out preventative health care, even if it is available to them.
For example, McCarthy et al. (23) found that for veterans
with psychosis, distance to medical care facilities was a major barrier to receiving preventative treatment. While individuals with other serious mental illness overcame this obstacle by scheduling multiple appointments on the same day,
individuals with schizophrenia did not. In addition, chronic
patients appear to have worse self-care than less chronic patients (24).

Methods for Assessing Functional
Disabilities

In the research literature, several domains have emerged
for understanding the disability of individuals with schizophrenia. These include self-report, informant report, observational ratings, achievement of major milestones, and
performance-based measures of functional skills. Although
there are benefits to all of these, many also have drawbacks.

Self-Report
Self-report is the standard method of assessing patient progress in clinical settings as providers routinely ask
patients about their progress. This method, which is also
widely used in research settings, has several advantages. Patients frequently have sole access to some aspects of the information that is useful in assessing disability. In addition,
patients are theoretically able to self-report subjective information that may be difficult for an outsider to determine,
such as mood state and motivation.
Unfortunately, individuals with schizophrenia are notoriously poor informants as they frequently exhibit limited
awareness of their psychotic symptoms (25). Furthermore,
in one study correlations between individuals with schizophrenia self-reports about cognitive deficits and their neuropsychological performance were almost zero, while correlations between informants’ ratings of cognitive deficits
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and patients’ neuropsychological performance was much
higher, r=0.40 (26). Additionally, case managers’ ratings of
functional outcomes were also more strongly correlated with
performance-based measures of functional capacity than
patients’ self-ratings (27). In this study, patient’s self-reports
were consistently uncorrelated with case manager reports of
everyday outcomes, such as employment and residential independence.

Informant Report
Informant reports have several advantages over selfreport. First, an informant report tends to be more objective than self-report. In addition, informants generally do
not exhibit the same degree of lack of insight and cognitive
impairments, such as problems with attention and memory,
frequently found in individuals with schizophrenia (28). Finally, obtaining information from multiple informants could
provide a broad view of the individual’s functioning.
Informant reports, however, are not without their limitations. Many individuals with schizophrenia lack a close
family member or friend who can serve as a reliable informant (29). Additionally, caregivers may not have access to
all behavior that is important for assessing disability. Caregivers may also exhibit their own biases that prevent them
from answering honestly or accurately. For example, caregivers may be afraid that if they provide positive ratings, patients may lose disability or medical benefits. Informants
also may lack an objective understanding of what constitutes
improvement or decline. For example, caregivers may not
have enough training or knowledge of illness factors to provide valid assessments of functioning in domains such as
social skills.

Observational Ratings
Observation ratings also have many important advantages. Trained observers are objective and skilled, and
therefore are most likely to provide a valid description of
behaviors of interest. Furthermore, observer ratings allow
an objective comparison between patients. They also allow
for the accurate assessment of changes within patients over
time, as objective observers may identify subtle improvements not apparent to patients or caregivers.
Observational ratings also have their drawbacks, the
first of which is their practicality. Behavior of interest may
occur infrequently and, therefore, in observing a patient for
a short amount of time one might miss it. In addition, observers can be very intrusive, and their presence can increase
the social stigma already experienced by these patients.

Assessing Major Milestones
Tracking the successful attainment of major milestones
achieved by individuals with schizophrenia is an important

aspect of understanding disability. For example, it is very
informative to know if individuals with schizophrenia
marry, transition to independent living, or obtain a degree.
Unfortunately, these milestones are rarely achieved by
individuals with schizophrenia and thus lack practicality as
a measurement tool to assess treatment progress. Further,
these milestones require time and effort for achievement in
the general population. It would be very unlikely that a shortterm follow-up study of achievement of these milestones in
healthy individuals would find a high rate of change in a
typical six-week study resembling a clinical treatment trial.

Performance-Based Measures of
Functional Skills
Performance-based measures of functional skills are
laboratory-based assessments during which participants are
asked to actually perform everyday tasks such as writing a
check or calling a friend to arrange a meeting. Performancebased measures, unlike other assessments, do not require
participants to be accurate with their self-report and are far
more cost efficient and practical than in vivo observations.
They also do not require the assessor to wait for the spontaneous performance, thus the behavior of interest can be
reliably assessed without a great time-cost for the examiner.
Finally, these measures allow for the assessment of an individual’s capabilities, rather than simply waiting to measure
what the individual does. These measures are gaining widespread acceptance in the research literature (see reference
#30 for a review of several performance-based measures),
but at present they are rarely used in clinical practice.
Performance-based measures of functioning for individuals with schizophrenia are available to assess most of
the domains of disability in this population (see Table 1 for
a summary of several promising performance-based measures). For example, The UCSD Performance-Based Skills
Assessment (UPSA; 31) is an office-based test measuring the
competence of individuals with schizophrenia at performing
day-to-day tasks in five domains: household chores, communication, finance, transportation, and planning recreational
activities. It has been found to have excellent reliability and
test-retest reliability, and to be highly sensitive to the difference between both individuals with schizophrenia and controls (31). The Social Skills Performance Assessment (SSPA;
12), on the other hand, is a performance-based test designed
to measure the social competence of individuals with schizophrenia. It consists of two role-played scenes: one scene in
which the subject is asked to greet a new neighbor (the interviewer) and one scene in which the subject telephones
his landlord (the interviewer) about a leak. Participants are
rated in eight categories, including interest/disinterest, fluency, clarity, focus, affect, grooming, and negotiation ability.
The SSPA successfully distinguishes between patients and
Clinical Schizophrenia & Related Psychoses July 2007
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normal controls and has been found to have excellent interwhich may require other opportunities, motivations, or skill
rater reliability and good test-retest reliability. Scores have
sets. Unfortunately, there are a host of variables that interbeen shown to correlate with negative symptoms, cognitive
vene between competence and performance, such as depresdeficits, and health-related quality of well being, but not with
sion, motivation, anxiety, fear of losing disability payments,
positive symptoms or degree of depression (12). There are
and discrimination, to name a few. Improving an individualso measures of vocational competence, such as COMPASS
al’s competence is a necessary first step in reducing disability,
Lite (Valpar International Corporation), a shortened version
but it may not be sufficient in changing performance in most
of Valpar’s Computerized Assessment (COMPASS) module.
or all cases. Thus, treatments aimed at reducing disability
This measure is a Table 1 Overview of Measures Assessing Areas of Disability
must target both the
computer-based,
individual’s ability
in Schizophrenia
c r i t e r i o n - r e f e rto engage in tasks,
Measure
Domain
Author
Time to Administer
enced assessment
and whether or
instrument
that
not the individual
Bay Area Functional
Everyday
Williams &
n/a
measures
vocaactually does perPerformance Evaluation
living
Bloomer (1987)
(BaFPE)
tional skills as they
form these tasks.
relate to jobs and
By measuring only
Direct Assessment of
Everyday
Lowenstein et al.
25
training programs,
real-world perforFunctional Status (DAFS)
living
(1989)
using the rating
mance one might
Test of Adaptive Behavior
Everyday
Velligan et al.
system of the Remiss
potential
in Schizophrenia (TABS)
living
(in press)
vised Handbook for
gains in the set of
UCSD Performance-Based
Everyday
Patterson et al.
30
Analyzing Jobs and
skill competencies,
Skills Assessment (UPSA)
living
(2001)
the Dictionary of
which are imporMaryland Assessment of
Social
Bellack et al.
n/a
Occupational Titles.
tant for the evenSocial Competence (MASC) competence
(1994)
Output
includes
tual deployment of
both the number
behavior, as well as
Social Skills Performance
Social
Patterson et al.
12
Assessment (SSPA)
competence
(2001)
and complexity of
the opportunity to
jobs for which the
understand factors
COMPASS
Vocational
Valpar International
60
individual is curthat interfere beaptitude
Corporation
rently qualified.
tween competence
COMPASS Lite
Vocational
Valpar International
30
Thus, perforand performance
aptitude
Corporation
mance-based asin the individual’s
Medication Management
Self-care
Patterson et al.
15 (after 1
sessments have the
case.
Ability Assessment
(2001)
hour delay)
flexibility to reliably
and validly meaNote: time to administer is in minutes; n/a = not available
sure an individual’s
competence without many of the drawbacks associated with
Non-Competence Factors Affecting
other methods for assessing aspects of disability. In addition,
Performance
these measures are available to assess functioning across a
There are several factors that could potentially impact
range of areas that are commonly associated with disability
performance of tasks related to disability beyond an individin schizophrenia.
ual’s ability to engage in those activities. For example, cognitive symptoms appear to be among the best predictors of
social competence and community functioning (13). In particular, verbal memory ability appears to be closely related to
community functioning (28), as are attention, speed, verbal
A major issue in the interpretation of functional disabillearning, and executive functioning (32). However, directly
ity in schizophrenia is that factors other than ability or comrelevant to this point is the recent finding by Rosenheck et al.
petence (what one can do) can have an impact on real-world
(13) indicating that while cognitive performance was correperformance (what one does). Treatments aimed at reduclated with occupational status in people with schizophrenia,
ing disability generally target an individual’s competence, for
racial and disability status, which are not realistic treatment
example, by teaching individuals with schizophrenia social
targets, have a much larger impact. In fact, although there
skills or job skills. However, they are aimed at real-world
appears to be a clear relationship between cognitive impairperformance, such as making a friend or obtaining a job,

The Distinction between
Competence and Performance
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ment and real-world disability, some abilities share only 10%
of the variance in everyday outcomes (28).
Thus, disability is influenced by a host of other factors,
some more amenable to change than others. Individuals
with schizophrenia, as noted above, rarely achieve milestones such as obtaining a job or marrying. Thus, they frequently have low expectations for success. In addition, individuals with schizophrenia frequently experience depressive
episodes (33). In fact, it has been estimated that as many as
75% of individuals with schizophrenia experience symptoms
of depression (33). Depressive symptoms, which have been
found to occur in individuals with schizophrenia across the
lifespan at first episode (34) and in late life (35), may also
perpetuate disability within this population. McGurk et
al. (36) recently found that individuals with schizophrenia
treated in a program that combined supportive employment
and cognitive rehabilitation worked more hours for better
wages, and also demonstrated lower scores on measures of
depression and autistic preoccupation. Thus, having success
in treatment and in the real world appears to have a beneficial impact on both an individual’s expectations and his or
her quality of life. Unfortunately, obtaining the first experience of success is not an easily obtainable goal for individuals with schizophrenia.
In addition, individuals with schizophrenia demonstrate a wide array of cognitive impairments (28) which impacts their ability to successfully deploy skills in real world
settings. They also demonstrate a focal impairment in their
ability to self-monitor, often referred to as “meta-cognition”
(37, 38), making it difficult to self-monitor and adjust behavior as needed in both social and occupational settings. Additionally, individuals with schizophrenia may not be able
to accurately assess whether tasks will be challenging and,
therefore, will require assistance.
Finally, the maintenance of disability in schizophrenia
is also affected by practical considerations, such as concerns
over losing disability income or medical benefits. Rosenheck et al. (13) found that individuals who received disability payments were less likely to be competitively employed
than those who did not. Individuals with schizophrenia
who work rarely make enough money to support themselves
(39); however, earning enough money to lose disability and
medical benefits may be a very real concern (13).

Suggestions for Clinicians

Functional disability is clearly an important aspect of
the schizophrenia disease process. However, standard clinical care for individuals with schizophrenia typically focuses
on reducing symptoms of psychosis rather than understanding and treating disability. We, therefore, believe that assessing an individual’s disability status should be an integral aspect of treatment. As noted above, current treatments very

effectively target the psychotic symptoms of schizophrenia,
symptoms that are clearly disruptive and unwanted. Unfortunately, though, effective treatment of psychosis rarely
translates into disability reduction. Numerous studies (for
a recent review, see reference #32) have demonstrated that
the cross-sectional severity of positive symptoms is a poor
predictor of functional outcome. Thus, although pharmacological interventions have often succeeded in treating the
positive symptoms of schizophrenia (4), there has been a
failure to translate symptom reduction into improved work
and social functioning (28, 40, 41). It is important to keep
in mind that for individuals with schizophrenia reduction of
symptoms is vastly different from illness recovery.
We also believe that obtaining adequate data is crucial
to successfully treating disability within this population.
While we acknowledge that it is important to obtain information about patients’ performance from patients themselves, as well as from caregivers, we caution that one cannot
assume that the information is correct. Biases inherent in
self-report and in caregiver ratings should always be kept in
mind. For instance, patients with schizophrenia appear to
show “depressive realism,” in that patients with more severe
depression (although still not to the extent of meeting diagnostic criteria for major depression) were actually more accurate at self-evaluation than those with less depression (27).
This data suggests that accuracy of self-report might vary
over time, changing along with the severity of concurrent
depression. However, related to this issue is the finding that
more severe depression is associated with relatively poorer
real-world outcomes than would be expected from scores on
competence measures (27). Thus, depression may increase
accuracy of self-evaluation but suppress the likelihood that
patients actually live up to their potential.
In addition, we believe that it is just as important to understand an individual’s competence as it is to understand his
or her real-world performance. Performance under optimal
conditions is the limiting factor for real-world outcomes.
Improved competence is a necessary part of improving performance, and examining progress in competence throughout treatment is, therefore, an important part of evaluating
its effectiveness. Furthermore, numerous factors intervene
between competence and performance. If one has a valid assessment of an individual’s competence, this can be used to
examine barriers to real-world performance of these skills.
Finally, it is crucial to eliminate extraneous barriers to
disability reduction whenever possible. Although some factors that relate to the maintenance of disability may not be
appropriate treatment targets, several factors are. In addition to pharmacological treatment of psychosis, therefore,
we propose that clinicians carefully attend to secondary illnesses such as depressive symptomatology and anxiety. The
widespread success of supportive employment programs in
Clinical Schizophrenia & Related Psychoses July 2007
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conjunction with skills training programs for individuals
with schizophrenia (16, 35) suggests that disability reduction is possible with the proper support and when factors
such as poor expectations and problems with self-monitoring are addressed. Thus, psychosocial treatments targeting
self-esteem and expectations, as well as residual effects from
prior discrimination and stigmatization, could help reduce
many barriers to disability reduction beyond an individual’s
competence.

Conclusions

Individuals with schizophrenia experience significant
disability across a wide range of arenas, including social
competence, vocational achievement, everyday living skills,
and self-care. This disability, which is responsible for great
cost to patients, caregivers, and society, appears to be a core
feature of schizophrenia as it is pervasive across domains of
functioning and across individual patients. We believe that
performance-based measures of functioning are the most
appropriate means of assessing disability in clinical settings
as they provide vital information about an individual’s skill
competence. As several factors intervene between competence and performance, understanding an individual’s
competence allows for a more accurate understanding of
barriers to disability reduction and can aid in more effective
treatment planning. Assessing functional disability in the
schizophrenia population is vital for providing appropriate
care with functional recovery, rather than symptom remission, as its goal.

Acknowledgments

This research was supported by NIMH Grant Number
MH 63116 to Dr. Harvey, the Mt. Sinai Silvio Conte Neuroscience Center (NIMH MH 36692; KL Davis PI), and the VA
VISN3 MIRECC.

References
1. Rice DP. Economic burden of mental disorders in the United
States. The Economics of Neuroscience 1999;1:40-44.
2. Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M,
et al. The economic burden of schizophrenia in the United
States in 2002. J Clin Psychiatry 2005;66:1122-1129.
3. Mueser KT, McGurk SR. Schizophrenia. Lancet 2004;363:20632072.
4. Marder SR, Meibach RC. Risperidone in the treatment of
schizophrenia. Am J Psychiatry 2004;151:825-835.
5. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen
G. One hundred years of schizophrenia: a meta-analysis of the
outcome literature. Am J Psychiatry 1994;151:1409-1416.
6. Kendler KS, McGuire M, Gruenberg AM, Walsh D. Outcome
and family study of the subtypes of schizophrenia in the west

152 •

Clinical Schizophrenia & Related Psychoses July 2007

of Ireland. Am J Psychiatry 1994;151:849-856.
7. Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: a review.
Schizophr Bull 2006;32(Suppl 1):S44-63.
8. Morrison RL, Bellack AS. Social functioning in schizophrenia patients: clinical and research issues. Schizophr Bull
1987;13:715-725.
9. Horan WP, Subotnik KL, Snyder KS, Nuechterlein KH. Do
recent-onset schizophrenia patients experience a “social network crisis?” Psychiatry 2006;69:115-129.
10. Sharma T, Antonova L. Cognitive function in schizophrenia.
Deficits, functional consequences, and future treatment. Psychiatr Clin North Am 2003;26:25-40.
11. Harvey PD, Velligan DI, Bellack AS. Performance-based
measures of functional skill: Usefulness in clinical treatment
studies. Schizophr Bull 2007 May 9; Epub ahead of print.
12. Patterson TL, Moscona S, McKibbin CL, Davidson K, Jeste
DV. Social skills performance assessment among older patients with schizophrenia. Schizophr Res 2001; 48:351-360.
13. Rosenheck R, Leslie D, Keefe R, McEvoy J, Swartz M, Perkins D, et al; CATIE Study Investigators Group. Barriers to
employment for people with schizophrenia. Am J Psychiatry
2006;163:411-417.
14. Mueser KT, Salyers MP, Mueser PR. A prospective analysis of
work in schizophrenia. Schizophr Bull 2001;27:281-296.
15. Bond GR. Supported employment: evidence for an evidencebased practice. Psychiatr Rehabil J 2004;27:345-359.
16. Bell MD, Bryson GJ, Greig TC, Fiszdon JM, Wexler BE. Neurocognitive enhancement therapy with work therapy: Productivity outcomes at 6- and 12-month follow-ups. J Rehabil
Res Dev 2005;42:829-838.
17. Dickerson FB, Ringel NB, Parente F. Subjective quality of life
in out-patients with schizophrenia: clinical and utilization
correlates. Acta Psychiatr Scand 1998;98:124-127.
18. Jaeger J, Berns SM, Czobor P. The multidimensional scale of
independent functioning: a new instrument for measuring
functional disability in psychiatric populations. Schizophr
Bull 2003;29:153-168.
19. Velligan DI, Mahurin RK, Diamond PL, Hazleton BC, Eckert
SL, Miller AL. The functional significance of symptomatology and cognitive function in schizophrenia. Schizophr Res
1997;25:21-31.
20. Velligan DM, Bow-Thomas CC, Huntzinger C, Ritch J, Ledbetter N, Prihoda TJ, et al. A randomized controlled trial of
the use of compensatory strategies to enhance adaptive functioning for outpatients with schizophrenia. Am J Psychiatry
2000;157:1317-1323.
21. Alptekin K, Erkoc S, Gogus AK, Kultur S, Mete L, Ucok
A, Yazici KM. Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up. Psychiatry Res
2005;135:103-111.
22. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical

Margaret M. McClure, Philip D. Harvey
findings. Schizophr Bull 1997;23:637-651.

and work in supported employment: a review and heuristic
model. Schizophr Res 2004;70:147-173.

23. McCarthy JF, Piette JD, Fortney JC, Valenstein M, Blow FC.
Outpatient visit chaining among patients with serious mental illness. Med Care 2006;44:257-264.

33. Siris SG. Depression in schizophrenia: perspective in the
era of “atypical” antipsychotic agents. Am J Psychiatry
2001;158:1379-1389.

24. Di Michele V, Bolino F, Mazza M, Roncone R, Casacchia M.
Relapsing versus non relapsing course of schizophrenia: a
cohort study in a community based mental health service.
Epidemiol Psichiatr Soc 2007;16:50-58.

34. Emsley RA, Oosthuizen PP, Joubert AF, Roberts MC, Stein
DJ. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. J Clin Psychiatry
1999;60:747-751.

25. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J,
Gorman JM. Assessment of insight in psychosis. Am J Psychiatry 1993;150:873-879.

35. Zisook S, Nyer M, Kasckow J, Golshan S, Lehman D, Montross L. Depressive symptom patterns in patients with chronic
schizophrenia and subsyndromal depression. Schizophr Res
2006;86:226-233.

26. Keefe RS, Poe M, Walker TM, Kang JW, Harvey PD. The
Schizophrenia Cognition Rating Scale: an interview-based
assessment and its relationship to cognition, real-world
functioning, and functional capacity. Am J Psychiatry
2006;163:426-432.

36. McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A.
Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial. Am J Psychiatry
2007;164:437-441.

27. Bowie CR, Twamley EW, Anderson H, Halpern B, Patterson TL, Harvey PD. Self-assessment of functional status in
schizophrenia. J Psychiatr Res 2006 Sep 30; Epub ahead of
print.

37. Koren D, Seidman LJ, Poyurovsky M, Goldsmith M, Viksman P, Zichel S, et al. The neuropsychological basis of insight
in first-episode schizophrenia: a pilot metacognitive study.
Schizophr Res 2004;70:195-202.

28. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry
1996;153:321-330.

38. Koren D, Poyurovsky M, Seidman LJ, Goldsmith M, Wenger
S, Klein EM. The neuropsychological basis of competence to
consent in first-episode schizophrenia: a pilot metacognitive
study. Biol Psychiatry 2005;57:609-616.

29. Patterson TL, Semple SJ, Shaw WS, Grant I, Jeste DV. Researching the caregiver: family members who care for older
psychotic patients. Psychiatr Ann 1996;26:772-784.

39. Becker D, Drake RE. A working life. New York: Oxford University Press; 2001.

30. Moore DJ, Palmer BW, Patterson TL, Jeste DV. A review of
performance-based measures of functional living skills. J
Psychiatr Res 2007;41:97-118.

40. McGurk SR, Meuser KT, Harvey PD, LaPuglia R, Marder J.
Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment. Psychiatr
Serv 2003;54:1129-1135.

31. Patterson TL, Goldman S, McKibbon CL, Hughs T, Jeste DV.
UCSD Performance-Based Skills Assessment: development
of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull 2001;27:235-245.

41. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff?” Schizophr Bull 2000;26:119-136.

32. McGurk SR, Meuser KT. Cognitive functioning, symptoms,

u

Clinical Schizophrenia & Related Psychoses July 2007

• 153

